A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

Clinical trial NCT01221298 · COMPLETED

Trial details

NCT number: NCT01221298
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C HCV Chronic Hepatitis C Infection Hepatitis C Genotype 1

Start date: 2010-10-01
Primary completion: 2011-05-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.